Immune cells in the bone marrow microenvironment of AML patients are key in distinguishing a response to immunotherapy.

A donor bone marrow transplant, also called allogeneic hematopoietic stem cell transplantation (alloHSCT), replaces unhealthy stem cells with healthy stem cells and is crucial for treating AML and ...

If Maggie O'Neil can't find a match among family members, she'll have to turn to a global nonprofit that connects volunteer ...

Nana Kwame Wiredu Amoako is currently fighting for his life against Acute Myeloid Leukaemia (AML), a severe form ... and now urgently requires a second bone marrow transplant along with further ...

AML, which affects four out of 100,000 patients in the U.S. every year, according to the National Cancer Institute, is a type of cancer that first attacks the bone marrow before moving to infect ...

This discovery paves the way for creation of T cell therapies with improved efficacy in treating AML." More information: Katie Maurer et al, Coordinated immune networks in leukemia bone marrow ...

The found that patients who responded to DLI therapy had notably different cellular populations in their bone marrow compared to patients who did not respond. The finding suggests that there might be ...

A 2-year-old boy who was diagnosed with a rare and aggressive cancer has received a life-saving bone marrow donation. Hezekiah “Hezzy” Martinez received a diagnosis for acute myeloid leukemia ...